<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/272693.xml</link>
<description>PRWeb.com Press Release Feed - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>New Alzheimer&#039;s Disease Survey Reveals Children of Sandwich Caregivers Assist with Loved Ones Care</title>
     <link>http://www.prweb.com/releases/2008/03/prweb750114.htm</link><description>   <![CDATA[ <P>Results from the third annual Alzheimer&#039;s Foundation of America (AFA) ICAN: Investigating Caregivers&#039; Attitudes and Needs Survey suggest that Alzheimer&#039;s disease care is a family affair. Most &quot;sandwich caregivers&quot; - the parents or guardians of children under 21 who also care for an aging parent, other relative or friend with Alzheimer&#039;s disease - say their children are assisting with caregiving responsibilities that range from attending doctors&#039; appointments to feeding and dressing their loved ones. (PRWeb Mar 26, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/03/prweb750114.htm">http://www.prweb.com/releases/2008/03/prweb750114.htm</a></P>]]>
                </description><pubDate>Wed, 26 Mar 2008 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/03/prweb750114.htm</guid>
        </item>
<item>
     <title>New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly</title>
     <link>http://www.prweb.com/releases/2008/03/prweb789024.htm</link><description>   <![CDATA[ <P>According to &quot;Attitudes About Allergies&quot;, a new national telephone survey, findings suggest that physical effects are not the only way we suffer, allergies impact mood and self-perception. (PRWeb Mar 20, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/03/prweb789024.htm">http://www.prweb.com/releases/2008/03/prweb789024.htm</a></P>]]>
                </description><pubDate>Thu, 20 Mar 2008 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/03/prweb789024.htm</guid>
        </item>
<item>
     <title>UCB Crohn&#039;s Scholarship Program to Award $300,000 to Students with Crohn&#039;s Disease </title>
     <link>http://www.prweb.com/releases/2008/01/prweb613871.htm</link><description>   <![CDATA[ <P>UCB announced the launch of the 2008 http://www.clickthat2006.com/UCB/scholarship [UCB Crohn&#039;s Scholarship] Program, which will award 30, one-time scholarships of up to $10,000 each to students diagnosed with Crohn&#039;s disease. Applications are now available at http://www.clickthat2006.com/UCB/scholarship [CrohnsAndMe.com], an online community created to help empower patients and supporters to live fully by being proactive in their care.  The 2008 program builds on $420,000 in UCB scholarships already granted for people with Crohn&#039;s seeking higher education. (PRWeb Jan 11, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/01/prweb613871.htm">http://www.prweb.com/releases/2008/01/prweb613871.htm</a></P>]]>
                </description><pubDate>Fri, 11 Jan 2008 08:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/01/prweb613871.htm</guid>
        </item>
<item>
     <title>Bystolic&#8482;, a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension</title>
     <link>http://www.prweb.com/releases/2007/12/prweb583752.htm</link><description>   <![CDATA[ <P> www.Frx.com [Forest Laboratories, Inc.] and Mylan Inc. announced today that the novel beta blocker www.Bystolic.com [Bystolic]&#8482; (nebivolol) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypertension.  Bystolic is a once daily medication that can be used alone or in combination with other hypertension treatments. (PRWeb Dec 18, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2007/12/prweb583752.htm">http://www.prweb.com/releases/2007/12/prweb583752.htm</a></P>]]>
                </description><pubDate>Tue, 18 Dec 2007 08:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2007/12/prweb583752.htm</guid>
        </item>
<item>
     <title>New Clinical Data Shows Chromium Picolinate Improves Cognitive Function </title>
     <link>http://www.prweb.com/releases/2007/12/prweb576401.htm</link><description>   <![CDATA[ <P>Nutrition 21, a leading developer and marketer of chromium-based and omega-3 fish oil-based nutritional supplements, announced the results of a clinical study that showed daily supplementation with 1000 mcg of chromium as chromium picolinate improved cognitive function in older adults experiencing early memory decline. The results of the randomized, double-blind, placebo-controlled study were recently presented to the medical community at a neurological meeting. (PRWeb Dec 13, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2007/12/prweb576401.htm">http://www.prweb.com/releases/2007/12/prweb576401.htm</a></P>]]>
                </description><pubDate>Thu, 13 Dec 2007 08:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2007/12/prweb576401.htm</guid>
        </item>
<item>
     <title>2007 Bipolar Disorder Awareness Campaign Emphasizes Importance of Accurate Diagnosis, Treatment and Recovery</title>
     <link>http://www.prweb.com/releases/2007/10/prweb560302.htm</link><description>   <![CDATA[ <P>The National Alliance on Mental Illness (NAMI) launches its 2007 Bipolar Disorder Awareness campaign, emphasizing the importance of accurate diagnosis and treatment for people living with bipolar disorder, including the role of mania and depression. (PRWeb Oct 11, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2007/10/prweb560302.htm">http://www.prweb.com/releases/2007/10/prweb560302.htm</a></P>]]>
                </description><pubDate>Thu, 11 Oct 2007 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2007/10/prweb560302.htm</guid>
        </item>
<item>
     <title>FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age First and Only Nasal Spray Influenza Vaccine for Young Children</title>
     <link>http://www.prweb.com/releases/2007/09/prweb555445.htm</link><description>   <![CDATA[ <P>MedImmune, Inc. (www.medimmune.com) today announced that the U.S. Food and Drug Administration (FDA) has approved the expanded use of FluMist(R) (www.FluMist.com) (Influenza Virus Vaccine Live, Intranasal) in children two to five years of age. FluMist is now approved for active immunization for the prevention of disease caused by influenza A and B viruses in individuals two to 49 years of age. Only one manufacturer had previously been licensed in the United States to produce influenza vaccine, in the form of a flu shot, for children under four years of age. (PRWeb Sep 22, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2007/09/prweb555445.htm">http://www.prweb.com/releases/2007/09/prweb555445.htm</a></P>]]>
                </description><pubDate>Sat, 22 Sep 2007 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2007/09/prweb555445.htm</guid>
        </item>
</channel>
</rss>